ARGENX BV
502091-8545ActiveEngineering life-changing immunology solutions for severe autoimmune diseases.
Overview
- 1–4
- Employees
- Unknown
- Revenue
- 2022
- Founded
Key Decision Makers
Wim Parys
Strategic Advisor to the R&D Committee
Peter Ulrichts
Chief Scientific Officer
Camilla Sylvest
Non-executive Director
Filip Borgions
Chief Technology Innovation Officer
+23 more contacts in Funnelfeedr
Description
argenx is a global immunology company dedicated to engineering life-changing therapeutic antibodies. They operate an advanced antibody innovation ecosystem where pioneering scientists collaborate closely with engineers. This structure accelerates the discovery of novel targets and differentiated the...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Utländsk juridisk person
- VAT Number
- SE502091854501
Decision Makers
27 contacts in FunnelfeedrWim Parys
Strategic Advisor to the R&D Committee
Peter Ulrichts
Chief Scientific Officer
Camilla Sylvest
Non-executive Director
Filip Borgions
Chief Technology Innovation Officer
Karl Gubitz
Chief Financial Officer
Karen Massey
Chief Executive Officer, Executive Director of the Board of Directors
Luc Truyen
Chief Medical Officer
Marc Schorpion
Global Head of Human Resources
Achim Plueckebaum
Global Head of Digital Technologies
Sandrine Piret‑Gerard
Chief Commercialization Officer
Andria Wilk
Global Head of Quality
Steve Krognes
Non-executive Director, Chairperson of the Audit and Compliance Committee, Member of the Remuneration & Nomination Committee
An Vandebosch
Head of Development
Tony Rosenberg
Non-executive Director, Vice Chairperson of the Board
Malini Moorthy
General Counsel
Dr. Pamela M. Klein
Non-executive Director
Dr. Ana Cespedes
Non-executive Director, Chairperson of the Remuneration & Nomination Committee
Hans de Haard
Co-Founder, Strategic Advisor to the R&D Committee
Mary Lynne Hedley
Strategic Advisor to the R&D Committee
Dr. Brian Kotzin
Non-executive Director and Chairperson of the R&D Committee
Tim Van Hauwermeiren
Co-Founder, Non-Independent Non-Executive Director and Chairperson of the Board
David L. Lacey
Strategic Advisor to the R&D Committee
Beth DelGiacco
Corporate Affairs
Other Contacts
Lynn Elton
Investor Relations (EU)
Erin Murphy
Media Relations
Arjen Lemmen
Corporate Development & Strategy
Alexandra Roy
Investor Relations (US)
Similar Companies
20 similar companies in FunnelfeedrAAX Biotech AB
5–9 employeesResearch-driven biotech advancing antibody therapies via proprietary technology.
ULTRAGENYX EUROPE GMBH
1–4 employeesAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Oblique Therapeutics AB (publ)
10–19 employeesInnovative biotech developing breakthrough antibodies using the AbiProt platform.
AMICUS THERAPEUTICS LTD
1–4 employeesGlobal biotechnology company developing transformative medicines for rare diseases.
Alexion Pharma Nordics AB
10–19 employeesPioneering transformative medicines for the global rare disease community.
Browse More
ARGENX BV Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo